Viatris has a total of 6094 patents globally, out of which 3339 have been granted. Of these 6094 patents, more than 23% patents are active. The USA is where Viatris has filed the maximum number of patents, followed by India and European Countries, it has generated an annual revenue of $17.88 billion in the year 2021. Parallelly, India seems to be the main focused R&D centre of Viatris.
Viatris was founded in the year 1961 by Milan Puskar and Don Panoz. Company is an American global pharmaceutical and healthcare corporation headquartered in Pennsylvania. As of December 2022, Viatris has a market cap of $13.07 Billion.
Do read about some of the most popular patents of Viatris which have been covered by us in this article and also you can find Viatris patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Viatris patent portfolio.
How many patents does Viatris have?
Viatris has a total of 6094 patents globally. These patents belong to 1544 unique patent families. Out of 6094 patents, 1460 patents are active.
How Many Patents did Viatris File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Viatris Applications Filed||Viatris Patents Granted|
How many Viatris patents are Alive/Dead?
How Many Patents did Viatris File in Different Countries?
Countries in which Viatris Filed Patents
|United States Of America||813|
|Hong Kong (S.A.R.)||151|
Where are Research Centres of Viatris Patents Located?
10 Best Viatris Patents
US6383500B1 is the most popular patent in the Viatris portfolio. It has received 174 citations so far from companies like Novo Nordisk A/S, Avant Medical Corporation, and Windgap Medical.
Below is the list of 10 most cited patents of Viatris:
|Publication Number||Citation Count|